Peer Support for Liver Transplant Recipients With History of ALD

Study acronym: THRIVE
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Start date pushed from Sep 2026 to Oct 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised
  2. Minor Start date: Aug 2026 to Sep 2026v5
  3. Minor Re-verified, no change to tracked fieldsv4
  4. Notable Start date: May 2026 to Aug 2026v3
  5. Notable Start date: Mar 2026 to May 2026v2
  6. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Liver transplant (LT) recipients with a history of alcohol-related liver disease (ALD) may encounter various psychosocial and medical challenges during post-LT recovery, even beyond the initial post-transplant period. Effective and sustainable interventions will be crucial for improving patient outcomes. This clinical trial will examine the impact of peer support specialists (PSS) on the recovery experience of individuals who received LT for ALD. The trial seeks to answer two main questions: * Are LT recipients who work with PSS less likely to resume alcohol use or tend to drink less overall? * Do LT recipients who work with PSS engage more with recommended medical care and have better overall survival?
Trial Details
NCT Number NCT07397598
Lead Sponsor Johns Hopkins University
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions
(from sponsor)
Alcohol Use Disorder, Alcohol Related Liver Disease, Liver Transplant Recipient
Related terms Alcoholism
Enrollment 95 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov